Anti-Mullerian hormone (AMH) is a protein that inhibits the development of the mullerian ducts (paramesonephric ducts) in the male embryo. AMH prevents the development of the mullerian ducts into the uterus and other mullerian structures in the first 8 weeks of gestational age. AMH is produced by granulosa cells of the ovary during the reproductive years and controls the formation of primary fo...

Submit Manuscript | http://medcraveonline.com Abbreviations: AMH: Anti-Mullerian Hormone; AR: Androgen Receptors; ATF3: Activating Transcription Factor 3; CPAs: Congenital Penile Anomalies; CWH: Chordee Without Hypospadias; EDCs: Endocrine Disrupting Chemicals; KFS: Klinefelter Syndrome; LUTS: Lower Urinary Tract Symptoms; MAGPI: Meatal Advancement and Glanuloplasty Incorporated; SMR: Split Med...

(2013) The relationship between anti-mullerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. The content must not be changed in any way or reproduced in any format or medium without the formal permission of the copyright holder(s) When referring to this work, full bibliographic details must be given

The strongest association between FMR1 and the ovary in humans is the increased risk of premature ovarian failure (POF) in women who carry the premutation level of CGG repeats (55-199 CGGs). Research on the FMR1 gene has extended to other endpoints of relevance in the OB/GYN setting for women, including infertility and ovarian hormones. After reviewing the nomenclature changes that have occurre...

The outcome of ovulation induction in anovulatory polycystic ovarian syndrome (PCOS) may depend, in part, on the pharmacologic compounds used, but also on individual patient characteristics, such as age, body mass index (BMI), hyperandrogenism, luteinizing hormone (LH), hyper-secretion, anti mullerian hormone (AMH) levels and possibly antral follicle count (AFC) with ovarian volume of these wom...

Subjects/Discussion. Two cases of clinical and radiological response of recurrent mixed Mullerian tumours following treatment with either nasal (Buserilin) or intramuscular (Goserilin) GnRH analogues are reported and a short review of the evidence to support this treatment option presented.

The Anti-Mullerian hormone (AMH), which is produced by fetal Sertoli cells, is responsible for regression of Mullerian ducts, the anlagen for uterus and Fallopian tubes, during male sex differentiation. Ovarian granulosa cells also secrete AMH from late in fetal life. The patterns of expression of AMH and its type II receptor in the post-natal ovary indicate that AMH may play an important role ...